I remember when Tysabri first came on the market a number of years ago for the "first" time.
Since I’m basing this assumption on my MSy memory, it may not be 100 % accurate. Please correct me if I’m wrong (unless it’s my wife or my mother-in-law reading this post.....the only two people from whom i will not tolerate being corrected....you do realise I’m joking...right ?
It seems to me that the results (of the Tysabri study) were so conclusive and that so many people were helped, that the FDA in the States, and other Health Boards from various counties, fast-tracked its application so that people could benefit from this treatment....then people started to die....they removed it. They brought it back as a mono-therapy, and fast-tracked it again.
If this is true, why can`t they fast-track diagnosis and treatment of CCSVI ?
Am I correct in being "suspicious" of decisions made by health authorities ?
Thanks ! Comments, corrections, misinterpretations (on my part) can be submitted, and are more than welcome.